Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Depreciation and Depletion (2016 - 2025)

Historic Depreciation and Depletion for BioCorRx (BICX) over the last 13 years, with Q3 2025 value amounting to $1474.0.

  • BioCorRx's Depreciation and Depletion fell 7704.05% to $1474.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $22076.0, marking a year-over-year decrease of 1402.76%. This contributed to the annual value of $31966.0 for FY2024, which is 2472.59% up from last year.
  • As of Q3 2025, BioCorRx's Depreciation and Depletion stood at $1474.0, which was down 7704.05% from $4130.0 recorded in Q2 2025.
  • BioCorRx's 5-year Depreciation and Depletion high stood at $12708.0 for Q4 2024, and its period low was $1474.0 during Q3 2025.
  • For the 5-year period, BioCorRx's Depreciation and Depletion averaged around $6369.1, with its median value being $6420.0 (2023).
  • In the last 5 years, BioCorRx's Depreciation and Depletion soared by 9794.39% in 2024 and then plummeted by 7704.05% in 2025.
  • Over the past 5 years, BioCorRx's Depreciation and Depletion (Quarter) stood at $6567.0 in 2021, then changed by 0.0% to $6567.0 in 2022, then dropped by 2.24% to $6420.0 in 2023, then surged by 97.94% to $12708.0 in 2024, then crashed by 88.4% to $1474.0 in 2025.
  • Its Depreciation and Depletion was $1474.0 in Q3 2025, compared to $4130.0 in Q2 2025 and $3764.0 in Q1 2025.